{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:34:45Z","timestamp":1789176885502,"version":"build-2803163510"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Healthy Brains, Healthy Lives"},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute exposure to cannabis has been associated with an array of cognitive alterations, increased risk for neuropsychiatric illness, and other neuropsychiatric sequelae including the emergence of acute psychotic symptoms. However, the brain alterations associating cannabis use and these behavioral and clinical phenotypes remains disputed. To this end, neuroimaging can be a powerful technique to non-invasively study the impact of cannabis exposure on brain structure and function in both humans and animal models. While chronic exposure studies provide insight into how use may be related to long-term outcomes, acute exposure may reveal interesting information regarding the immediate impact of use and abuse on brain circuits. Understanding these alterations could reveal the connection with symptom dimensions in neuropsychiatric disorders and, more specifically with psychosis. The purpose of the present review is to: 1) provide an update on the findings of pharmacological neuroimaging studies examining the effects of administered cannabinoids and 2) focus the discussion on studies that examine the sensitive window for the emergence of psychosis. Current literature indicates that cannabis exposure has varied effects on the brain, with the principal compounds in cannabis (delta-9-tetrahydrocannabinol and cannabidiol) altering activity across different brain regions. Importantly, we also discovered critical gaps in the literature, particularly regarding sex-dependent responses and long-term effects of chronic exposure. Certain networks often characterized as dysregulated in psychosis, like the default mode network and limbic system, were also impacted by THC exposure, identifying areas of particular interest for future work investigating the potential relationship between the two.<\/jats:p>","DOI":"10.1038\/s41398-021-01295-w","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T10:05:57Z","timestamp":1618308357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5015-0574","authenticated-orcid":false,"given":"Lani","family":"Cupo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Guma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"1295_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.puhe.2019.08.018","volume":"178","author":"S Lancione","year":"2020","unstructured":"Lancione, S. et al. Non-medical cannabis in North America: an overview of regulatory approaches. Public Health 178, 7\u201314 (2020).","journal-title":"Public Health"},{"key":"1295_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.drugpo.2015.01.009","volume":"26","author":"RA Miech","year":"2015","unstructured":"Miech, R. A. et al. Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: the case of California 2007-2013. Int. J. Drug Policy 26, 336\u2013344 (2015).","journal-title":"Int. J. Drug Policy"},{"key":"1295_CR3","first-page":"109","volume":"73","author":"CW Webb","year":"2014","unstructured":"Webb, C. W. & Webb, S. M. Therapeutic benefits of cannabis: a patient survey. Hawaii J. Med. Public Health 73, 109\u2013111 (2014).","journal-title":"Hawaii J. Med. Public Health"},{"key":"1295_CR4","doi-asserted-by":"publisher","unstructured":"MacMillan, K., MacMillan, K. M., Keddy, A. & Furlong, J. Cannabis and glaucoma: a literature review. Dalhous. Med. J. https:\/\/doi.org\/10.15273\/dmj.vol46no1.9830. (2019).","DOI":"10.15273\/dmj.vol46no1.9830"},{"key":"1295_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow, N. D. et al. Effects of Cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry 73, 292\u2013297 (2016).","journal-title":"JAMA Psychiatry"},{"key":"1295_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.drugalcdep.2012.06.002","volume":"126","author":"LJ Horwood","year":"2012","unstructured":"Horwood, L. J. et al. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend. 126, 369\u2013378 (2012).","journal-title":"Drug Alcohol Depend."},{"key":"1295_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/chi.0b013e31802dc54d","volume":"46","author":"MR Hayatbakhsh","year":"2007","unstructured":"Hayatbakhsh, M. R. et al. Cannabis and anxiety and depression in young adults: a large prospective study. J. Am. Acad. Child Adolesc. Psychiatry 46, 408\u2013417 (2007).","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"1295_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2013.10.018","volume":"151","author":"GP Davis","year":"2013","unstructured":"Davis, G. P., Compton, M. T., Wang, S., Levin, F. R. & Blanco, C. Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on alcohol and related conditions. Schizophr. Res. 151, 197\u2013202 (2013).","journal-title":"Schizophr. Res."},{"key":"1295_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","volume":"325","author":"L Arseneault","year":"2002","unstructured":"Arseneault, L. et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325, 1212\u20131213 (2002).","journal-title":"BMJ"},{"key":"1295_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"DC D\u2019Souza","year":"2004","unstructured":"D\u2019Souza, D. C. et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558\u20131572 (2004).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1073858411422114","volume":"18","author":"W Kilb","year":"2012","unstructured":"Kilb, W. Development of the GABAergic system from birth to adolescence. Neuroscientist 18, 613\u2013630 (2012).","journal-title":"Neuroscientist"},{"key":"1295_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature20153","volume":"539","author":"MAP Bloomfield","year":"2016","unstructured":"Bloomfield, M. A. P., Ashok, A. H., Volkow, N. D. & Howes, O. D. The effects of \u03949-tetrahydrocannabinol on the dopamine system. Nature 539, 369\u2013377 (2016).","journal-title":"Nature"},{"key":"1295_CR13","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.1523\/JNEUROSCI.0736-10.2010","volume":"30","author":"CQ Chiu","year":"2010","unstructured":"Chiu, C. Q., Puente, N., Grandes, P. & Castillo, P. E. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 30, 7236\u20137248 (2010).","journal-title":"J. Neurosci."},{"key":"1295_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham, M. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563\u2013583 (1991).","journal-title":"J. Neurosci."},{"key":"1295_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11920-007-0041-7","volume":"9","author":"M Toda","year":"2007","unstructured":"Toda, M. & Abi-Dargham, A. Dopamine hypothesis of schizophrenia: making sense of it all. Curr. Psychiatry Rep. 9, 329\u2013336 (2007).","journal-title":"Curr. Psychiatry Rep."},{"key":"1295_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes, O., McCutcheon, R. & Stone, J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J. Psychopharmacol. 29, 97\u2013115 (2015).","journal-title":"J. Psychopharmacol."},{"key":"1295_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","volume":"24","author":"E Plitman","year":"2014","unstructured":"Plitman, E. et al. Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur. Neuropsychopharmacol. 24, 1591\u20131605 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1295_CR18","unstructured":"Nudmamud-Thanoi, S. et al. in Neuropsychiatric Disorders: An Integrative Approach 281\u2013285 (Springer, 2007)."},{"key":"1295_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","volume":"17","author":"C Silvestri","year":"2013","unstructured":"Silvestri, C. & Di Marzo, V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 17, 475\u2013490 (2013).","journal-title":"Cell Metab."},{"key":"1295_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","volume":"112","author":"AC Campos","year":"2016","unstructured":"Campos, A. C., Foga\u00e7a, M. V., Sonego, A. B. & Guimar\u00e3es, F. S. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharm. Res. 112, 119\u2013127 (2016).","journal-title":"Pharm. Res."},{"key":"1295_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","volume":"6","author":"M Di Forti","year":"2019","unstructured":"Di Forti, M. et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry 6, 427\u2013436 (2019).","journal-title":"Lancet Psychiatry"},{"key":"1295_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2010.11.031","volume":"117","author":"JR Burgdorf","year":"2011","unstructured":"Burgdorf, J. R., Kilmer, B. & Pacula, R. L. Heterogeneity in the composition of marijuana seized in California. Drug Alcohol Depend. 117, 59\u201361 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"1295_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","volume":"161","author":"ND Veen","year":"2004","unstructured":"Veen, N. D. et al. Cannabis use and age at onset of schizophrenia. Am. J. Psychiatry 161, 501\u2013506 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"1295_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/09540261.2010.515205","volume":"22","author":"KM Abel","year":"2010","unstructured":"Abel, K. M., Drake, R. & Goldstein, J. M. Sex differences in schizophrenia. Int. Rev. Psychiatry 22, 417\u2013428 (2010).","journal-title":"Int. Rev. Psychiatry"},{"key":"1295_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11065-012-9222-1","volume":"23","author":"NA Crane","year":"2013","unstructured":"Crane, N. A., Schuster, R. M., Fusar-Poli, P. & Gonzalez, R. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol. Rev. 23, 117\u2013137 (2013).","journal-title":"Neuropsychol. Rev."},{"key":"1295_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ntr\/ntr043","volume":"13","author":"RE B\u00e9langer","year":"2011","unstructured":"B\u00e9langer, R. E., Akre, C., Kuntsche, E., Gmel, G. & Suris, J.-C. Adding tobacco to cannabis its frequency and likely implications. Nicotine Tob. Res. 13, 746\u2013750 (2011).","journal-title":"Nicotine Tob. Res."},{"key":"1295_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.11.002","volume":"101","author":"H Pape","year":"2009","unstructured":"Pape, H., Rossow, I. & Storvoll, E. E. Under double influence: assessment of simultaneous alcohol and cannabis use in general youth populations. Drug Alcohol Depend. 101, 69\u201373 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"1295_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hup.950","volume":"23","author":"NT Van Dam","year":"2008","unstructured":"Van Dam, N. T., Earleywine, M. & DiGiacomo, G. Polydrug use, cannabis, and psychosis-like symptoms. Hum. Psychopharmacol. 23, 475\u2013485 (2008).","journal-title":"Hum. Psychopharmacol."},{"key":"1295_CR29","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/mp.2014.51","volume":"19","author":"RA Power","year":"2014","unstructured":"Power, R. A. et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol. Psychiatry 19, 1201\u20131204 (2014).","journal-title":"Mol. Psychiatry"},{"key":"1295_CR30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ajmg.b.30959","volume":"153B","author":"E Hare","year":"2010","unstructured":"Hare, E. et al. Heritability of age of onset of psychosis in schizophrenia. Am. J. Med. Genet. B 153B, 298\u2013302 (2010).","journal-title":"Am. J. Med. Genet. B"},{"key":"1295_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.schres.2009.05.017","volume":"113","author":"S K\u00f6hler","year":"2009","unstructured":"K\u00f6hler, S. et al. Evidence that better outcome of psychosis in women is reversed with increasing age of onset: a population-based 5-year follow-up study. Schizophr. Res. 113, 226\u2013232 (2009).","journal-title":"Schizophr. Res."},{"key":"1295_CR32","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.2174\/13816128113199990432","volume":"20","author":"A Batalla","year":"2014","unstructured":"Batalla, A. et al. Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review. Curr. Pharm. Des. 20, 2168\u20132185 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"1295_CR33","doi-asserted-by":"crossref","unstructured":"Crocker, C. E., Cookey, J. & Tibbo P. G. in Handbook of Cannabis and Related Pathologies (ed. Preedy, V. R.) 345\u2013356 (Academic Press, 2017).","DOI":"10.1016\/B978-0-12-800756-3.00041-7"},{"key":"1295_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbr.2017.02.025","volume":"325","author":"AD Meruelo","year":"2017","unstructured":"Meruelo, A. D., Castro, N., Cota, C. I. & Tapert, S. F. Cannabis and alcohol use, and the developing brain. Behav. Brain Res. 325, 44\u201350 (2017).","journal-title":"Behav. Brain Res."},{"key":"1295_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1742-9994-12-S1-S17","volume":"12","author":"V Brust","year":"2015","unstructured":"Brust, V., Schindler, P. M. & Lewejohann, L. Lifetime development of behavioural phenotype in the house mouse (Mus musculus). Front. Zool. 12, S17 (2015).","journal-title":"Front. Zool."},{"key":"1295_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","volume":"24","author":"LP Spear","year":"2000","unstructured":"Spear, L. P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24, 417\u2013463 (2000).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1295_CR37","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1017\/S0033291712001924","volume":"43","author":"Z Atakan","year":"2013","unstructured":"Atakan, Z. et al. Cannabis affects people differently: inter-subject variation in the psychotogenic effects of \u03949-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. Psychol. Med. 43, 1255\u20131267 (2013).","journal-title":"Psychol. Med."},{"key":"1295_CR38","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1017\/S0033291714000920","volume":"44","author":"S Bhattacharyya","year":"2014","unstructured":"Bhattacharyya, S. et al. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychol. Med. 44, 3315\u20133328 (2014).","journal-title":"Psychol. Med."},{"key":"1295_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1162\/jocn_a_00156","volume":"24","author":"MG Bossong","year":"2012","unstructured":"Bossong, M. G. et al. Effects of \u03949-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. J. Cogn. Neurosci. 24, 588\u2013599 (2012).","journal-title":"J. Cogn. Neurosci."},{"key":"1295_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopsych.2012.01.008","volume":"71","author":"MG Bossong","year":"2012","unstructured":"Bossong, M. G. et al. Effects of \u03b49-tetrahydrocannabinol on human working memory function. Biol. Psychiatry 71, 693\u2013699 (2012).","journal-title":"Biol. Psychiatry"},{"key":"1295_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070074","volume":"8","author":"MG Bossong","year":"2013","unstructured":"Bossong, M. G. et al. Default mode network in the effects of \u03949-Tetrahydrocannabinol (THC) on human executive function. PLoS ONE 8, e70074 (2013).","journal-title":"PLoS ONE"},{"key":"1295_CR42","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","volume":"23","author":"MG Bossong","year":"2013","unstructured":"Bossong, M. G. et al. The endocannabinoid system and emotional processing: a pharmacological fMRI study with \u22069-tetrahydrocannabinol. Eur. Neuropsychopharmacol. 23, 1687\u20131697 (2013).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1295_CR43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1037\/pha0000221","volume":"26","author":"M Colizzi","year":"2018","unstructured":"Colizzi, M. et al. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. Exp. Clin. Psychopharmacol. 26, 582\u2013598 (2018).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"1295_CR44","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.euroneuro.2018.04.003","volume":"28","author":"M Colizzi","year":"2018","unstructured":"Colizzi, M. et al. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. Eur. Neuropsychopharmacol. 28, 850\u2013862 (2018).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1295_CR45","doi-asserted-by":"publisher","unstructured":"Colizzi, M. et al. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-019-0374-8. (2019).","DOI":"10.1038\/s41380-019-0374-8"},{"key":"1295_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/adb.12351","volume":"22","author":"EB de Sousa Fernandes Perna","year":"2017","unstructured":"de Sousa Fernandes Perna, E. B. et al. Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication. Addict. Biol. 22, 823\u2013832 (2017).","journal-title":"Addict. Biol."},{"key":"1295_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.6","volume":"3","author":"JM Jansma","year":"2013","unstructured":"Jansma, J. M. et al. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Transl. Psychiatry 3, e234 (2013).","journal-title":"Transl. Psychiatry"},{"key":"1295_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.neuroimage.2012.07.051","volume":"63","author":"LE Klumpers","year":"2012","unstructured":"Klumpers, L. E. et al. Manipulating brain connectivity with \u03b49-tetrahydrocannabinol: a pharmacological resting state FMRI study. Neuroimage 63, 1701\u20131711 (2012).","journal-title":"Neuroimage"},{"key":"1295_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pain.2012.09.017","volume":"154","author":"MC Lee","year":"2013","unstructured":"Lee, M. C. et al. Amygdala activity contributes to the dissociative effect of Cannabis on pain perception. Pain 154, 124\u2013134 (2013).","journal-title":"Pain"},{"key":"1295_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0024-3205(93)90239-Y","volume":"52","author":"RJ Mathew","year":"1993","unstructured":"Mathew, R. J. & Wilson, W. H. Acute changes in cerebral blood flow after smoking marijuana. Life Sci. 52, 757\u2013767 (1993).","journal-title":"Life Sci."},{"key":"1295_CR51","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/jcbfm.1992.106","volume":"12","author":"RJ Mathew","year":"1992","unstructured":"Mathew, R. J., Wilson, W. H., Humphreys, D. F., Lowe, J. V. & Wiethe, K. E. Regional cerebral blood flow after marijuana smoking. J. Cereb. Blood Flow. Metab. 12, 750\u2013758 (1992).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1295_CR52","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/00001756-200306110-00009","volume":"14","author":"DS O\u2019Leary","year":"2003","unstructured":"O\u2019Leary, D. S. et al. Marijuana alters the human cerebellar clock. Neuroreport 14, 1145\u20131151 (2003).","journal-title":"Neuroreport"},{"key":"1295_CR53","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11682-015-9488-z","volume":"10","author":"JG Ramaekers","year":"2016","unstructured":"Ramaekers, J. G. et al. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes. Brain Imaging Behav. 10, 1254\u20131263 (2016).","journal-title":"Brain Imaging Behav."},{"key":"1295_CR54","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1017\/S1461145711000526","volume":"14","author":"HH van Hell","year":"2011","unstructured":"van Hell, H. H. et al. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. Int. J. Neuropsychopharmacol. 14, 1377\u20131388 (2011).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1295_CR55","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00213-011-2428-8","volume":"219","author":"HH van Hell","year":"2012","unstructured":"van Hell, H. H. et al. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology 219, 981\u2013990 (2012).","journal-title":"Psychopharmacology"},{"key":"1295_CR56","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/npp.2015.336","volume":"41","author":"C Walter","year":"2016","unstructured":"Walter, C. et al. Brain mapping-based model of \u0394(9)-tetrahydrocannabinol effects on connectivity in the pain matrix. Neuropsychopharmacology 41, 1659\u20131669 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR57","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/npp.2008.138","volume":"34","author":"MG Bossong","year":"2009","unstructured":"Bossong, M. G. et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34, 759\u2013766 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR58","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00228-017-2331-2","volume":"73","author":"C Walter","year":"2017","unstructured":"Walter, C. et al. Effects of oral \u03949-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects. Eur. J. Clin. Pharm. 73, 1579\u20131587 (2017).","journal-title":"Eur. J. Clin. Pharm."},{"key":"1295_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052545","volume":"8","author":"G Battistella","year":"2013","unstructured":"Battistella, G. et al. Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving. PLoS ONE 8, e52545 (2013).","journal-title":"PLoS ONE"},{"key":"1295_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hup.832","volume":"22","author":"DS O\u2019leary","year":"2007","unstructured":"O\u2019leary, D. S. et al. Effects of smoking marijuana on focal attention and brain blood flow. Hum. Psychopharmacol. 22, 135\u2013148 (2007).","journal-title":"Hum. Psychopharmacol."},{"key":"1295_CR61","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/npp.2015.359","volume":"41","author":"SM Gorka","year":"2016","unstructured":"Gorka, S. M. et al. Cannabinoid modulation of frontolimbic activation and connectivity during volitional regulation of negative affect. Neuropsychopharmacology 41, 1888\u20131896 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR62","doi-asserted-by":"publisher","unstructured":"Gorka, S. M., Fitzgerald, D. A., de Wit, H. & Phan, K. L. Cannabinoid modulation of amygdala subregion functional connectivity to social signals of threat. Int. J. Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyu104. (2014).","DOI":"10.1093\/ijnp\/pyu104"},{"key":"1295_CR63","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","volume":"28","author":"KL Phan","year":"2008","unstructured":"Phan, K. L. et al. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J. Neurosci. 28, 2313\u20132319 (2008).","journal-title":"J. Neurosci."},{"key":"1295_CR64","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00702-011-0747-x","volume":"119","author":"CA Rabinak","year":"2012","unstructured":"Rabinak, C. A., Sripada, C. S., Angstadt, M., de Wit, H. & Phan, K. L. Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J. Neural Transm. 119, 701\u2013707 (2012).","journal-title":"J. Neural Transm."},{"key":"1295_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuropharm.2018.10.002","volume":"143","author":"CA Rabinak","year":"2018","unstructured":"Rabinak, C. A., Peters, C., Marusak, H. A., Ghosh, S. & Phan, K. L. Effects of acute \u03949-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics. Neuropharmacology 143, 289\u2013298 (2018).","journal-title":"Neuropharmacology"},{"key":"1295_CR66","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1177\/0269881110382465","volume":"25","author":"E Barkus","year":"2011","unstructured":"Barkus, E. et al. Does intravenous \u03949-tetrahydrocannabinol increase dopamine release? A SPET study. J. Psychopharmacol. 25, 1462\u20131468 (2011).","journal-title":"J. Psychopharmacol."},{"key":"1295_CR67","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","volume":"66","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya, S. et al. Modulation of mediotemporal and ventrostriatal function in humans by \u03949-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch. Gen. Psychiatry 66, 442\u2013451 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1295_CR68","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","volume":"35","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya, S. et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35, 764\u2013774 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","volume":"69","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya, S. et al. Induction of psychosis by \u03949-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch. Gen. Psychiatry 69, 27\u201336 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1295_CR70","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","volume":"64","author":"SJ Borgwardt","year":"2008","unstructured":"Borgwardt, S. J. et al. Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol. Psychiatry 64, 966\u2013973 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1295_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","volume":"66","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli, P. et al. Distinct effects of \u03949-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch. Gen. Psychiatry 66, 95\u2013105 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1295_CR72","doi-asserted-by":"crossref","unstructured":"Rzepa, E., Tudge, L. & McCabe, C. The CB1 neutral antagonist tetrahydrocannabivarin reduces default mode network and increases executive control network resting state functional connectivity in healthy volunteers. Int. J. Neuropsychopharmacol. https:\/\/academic.oup.com\/ijnp\/article-abstract\/19\/2\/pyv092\/2910095. (2016).","DOI":"10.1093\/ijnp\/pyv092"},{"key":"1295_CR73","doi-asserted-by":"publisher","unstructured":"Tudge, L., Williams, C., Cowen, P. J. & McCabe, C. Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers. Int. J. Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyu094. (2014).","DOI":"10.1093\/ijnp\/pyu094"},{"key":"1295_CR74","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","volume":"75","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya, S. et al. Effect of Cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial. JAMA Psychiatry 75, 1107\u20131117 (2018).","journal-title":"JAMA Psychiatry"},{"key":"1295_CR75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuroimage.2007.11.020","volume":"40","author":"NY Seiferth","year":"2008","unstructured":"Seiferth, N. Y. et al. Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage 40, 289\u2013297 (2008).","journal-title":"Neuroimage"},{"key":"1295_CR76","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/schbul\/sbx198","volume":"45","author":"SL Fryer","year":"2019","unstructured":"Fryer, S. L. et al. Should I stay or should I go? FMRI Study of response inhibition in early illness schizophrenia and risk for psychosis. Schizophr. Bull. 45, 158\u2013168 (2019).","journal-title":"Schizophr. Bull."},{"key":"1295_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.schres.2012.05.005","volume":"139","author":"A Alonso-Sol\u00eds","year":"2012","unstructured":"Alonso-Sol\u00eds, A. et al. Altered default network resting state functional connectivity in patients with a first episode of psychosis. Schizophr. Res. 139, 13\u201318 (2012).","journal-title":"Schizophr. Res."},{"key":"1295_CR78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pscychresns.2010.05.003","volume":"183","author":"C de la Fuente-Sandoval","year":"2010","unstructured":"de la Fuente-Sandoval, C., Favila, R., G\u00f3mez-Martin, D., Pellicer, F. & Graff-Guerrero, A. Functional magnetic resonance imaging response to experimental pain in drug-free patients with schizophrenia. Psychiatry Res. 183, 99\u2013104 (2010).","journal-title":"Psychiatry Res."},{"key":"1295_CR79","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/npp.2012.91","volume":"37","author":"N Ginovart","year":"2012","unstructured":"Ginovart, N. et al. Chronic \u03949-tetrahydrocannabinol exposure induces a sensitization of dopamine D2\/3 receptors in the mesoaccumbens and nigrostriatal systems. Neuropsychopharmacology 37, 2355\u20132367 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1527-3458.2001.tb00192.x","volume":"7","author":"A Ottani","year":"2006","unstructured":"Ottani, A. & Giuliani, D. HU 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev. 7, 131\u2013145 (2006).","journal-title":"CNS Drug Rev."},{"key":"1295_CR81","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainresbull.2011.11.011","volume":"87","author":"VH Nguyen","year":"2012","unstructured":"Nguyen, V. H. et al. Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG. Brain Res. Bull. 87, 172\u2013179 (2012).","journal-title":"Brain Res. Bull."},{"key":"1295_CR82","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/sj.npp.1301467","volume":"33","author":"A Higuera-Matas","year":"2008","unstructured":"Higuera-Matas, A. et al. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology 33, 806\u2013813 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR83","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jchemneu.2010.07.005","volume":"40","author":"VS Dalton","year":"2010","unstructured":"Dalton, V. S. & Zavitsanou, K. Differential treatment regimen-related effects of cannabinoids on D1 and D2 receptors in adolescent and adult rat brain. J. Chem. Neuroanat. 40, 272\u2013280 (2010).","journal-title":"J. Chem. Neuroanat."},{"key":"1295_CR84","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","volume":"13","author":"AC Howlett","year":"1990","unstructured":"Howlett, A. C. et al. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13, 420\u2013423 (1990).","journal-title":"Trends Neurosci."},{"key":"1295_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1124\/jpet.117.244194","volume":"364","author":"WS John","year":"2018","unstructured":"John, W. S. et al. Chronic \u03949-THC in rhesus monkeys: effects on cognitive performance and dopamine D2\/D3 receptor availability. J. Pharm. Exp. Ther. 364, 300\u2013310 (2018).","journal-title":"J. Pharm. Exp. Ther."},{"key":"1295_CR86","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/npp.2011.17","volume":"36","author":"T Winton-Brown","year":"2011","unstructured":"Winton-Brown, T. et al. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology 36, 1340\u20131348 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR87","doi-asserted-by":"publisher","unstructured":"Valdeolivas, S., Sagredo, O., Delgado, M., Pozo, M. A. & Fern\u00e1ndez-Ruiz, J. Effects of a sativex-like combination of phytocannabinoids on disease progression in R6\/2 mice, an experimental model of Huntington\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18040684. (2017).","DOI":"10.3390\/ijms18040684"},{"key":"1295_CR88","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroimage.2009.06.029","volume":"48","author":"PRA Stokes","year":"2009","unstructured":"Stokes, P. R. A., Mehta, M. A., Curran, H. V., Breen, G. & Grasby, P. M. Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage 48, 186\u2013190 (2009).","journal-title":"Neuroimage"},{"key":"1295_CR89","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","volume":"22","author":"N Ben-Jonathan","year":"2001","unstructured":"Ben-Jonathan, N. & Hnasko, R. Dopamine as a prolactin (PRL) inhibitor. Endocr. Rev. 22, 724\u2013763 (2001).","journal-title":"Endocr. Rev."},{"key":"1295_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/mp.2011.20","volume":"16","author":"O Howes","year":"2011","unstructured":"Howes, O. et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol. Psychiatry 16, 85\u2013886 (2011). 8.","journal-title":"Mol. Psychiatry"},{"key":"1295_CR91","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham, A. et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl Acad. Sci. USA 97, 8104\u20138109 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1295_CR92","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham, A. et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761\u2013767 (1998).","journal-title":"Am. J. Psychiatry"},{"key":"1295_CR93","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.schres.2014.03.033","volume":"156","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Disrupted resting-state functional connectivity in minimally treated chronic schizophrenia. Schizophr. Res. 156, 150\u2013156 (2014).","journal-title":"Schizophr. Res."},{"key":"1295_CR94","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-0447.2011.01787.x","volume":"125","author":"SIJ Schutters","year":"2012","unstructured":"Schutters, S. I. J. et al. The association between social phobia, social anxiety cognitions and paranoid symptoms. Acta Psychiatr. Scand. 125, 213\u2013227 (2012).","journal-title":"Acta Psychiatr. Scand."},{"key":"1295_CR95","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij, N. et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287, 1123\u20131131 (2002).","journal-title":"JAMA"},{"key":"1295_CR96","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S1461145712000314","volume":"16","author":"C de la Fuente-Sandoval","year":"2013","unstructured":"de la Fuente-Sandoval, C. et al. Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. Int. J. Neuropsychopharmacol. 16, 471\u2013475 (2013).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1295_CR97","unstructured":"Taconic Biosciences, Inc. Sprague Dawley Rat. https:\/\/www.taconic.com\/pdfs\/sprague-dawley-rat.pdf."},{"key":"1295_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184923","volume":"12","author":"HR Cremers","year":"2017","unstructured":"Cremers, H. R., Wager, T. D. & Yarkoni, T. The relation between statistical power and inference in fMRI. PLoS One 12, e0184923 (2017).","journal-title":"PLoS One"},{"key":"1295_CR99","doi-asserted-by":"publisher","unstructured":"Turner B. O., Paul E. J., Miller M. B., Barbey A. K. Small sample sizes reduce the replicability of task-based fMRI studies. Communications Biology. 2018; 1. https:\/\/doi.org\/10.1038\/s42003-018-0073-z.","DOI":"10.1038\/s42003-018-0073-z"},{"key":"1295_CR100","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-014-3855-0","volume":"232","author":"JX Haensel","year":"2015","unstructured":"Haensel, J. X., Spain, A. & Martin, C. A systematic review of physiological methods in rodent pharmacological MRI studies. Psychopharmacology 232, 489\u2013499 (2015).","journal-title":"Psychopharmacology"},{"key":"1295_CR101","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10334-006-0048-9","volume":"19","author":"O Beuf","year":"2006","unstructured":"Beuf, O., Jaillon, F., Saint-Jalmes, H. & Small-animal, M. R. I. signal-to-noise ratio comparison at 7 and 1.5 T with multiple-animal acquisition strategies. MAGMA 19, 202\u2013208 (2006).","journal-title":"MAGMA"},{"key":"1295_CR102","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/clpt.1980.181","volume":"28","author":"A Ohlsson","year":"1980","unstructured":"Ohlsson, A. et al. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharm. Ther. 28, 409\u2013416 (1980).","journal-title":"Clin. Pharm. Ther."},{"key":"1295_CR103","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn3475","volume":"14","author":"KS Button","year":"2013","unstructured":"Button, K. S. et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 14, 365\u2013376 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"1295_CR104","doi-asserted-by":"publisher","unstructured":"Hasan A., et al. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci 2019. https:\/\/doi.org\/10.1007\/s00406-019-01068-z.","DOI":"10.1007\/s00406-019-01068-z"},{"key":"1295_CR105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2017.02.026","volume":"189","author":"TE Mwansisya","year":"2017","unstructured":"Mwansisya, T. E. et al. Task and resting-state fMRI studies in first-episode schizophrenia: A systematic review. Schizophr. Res 189, 9\u201318 (2017).","journal-title":"Schizophr. Res"},{"key":"1295_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-clinpsy-032511-143049","volume":"8","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli, S. & Ford, J. M. Default mode network activity and connectivity in psychopathology. Annu Rev. Clin. Psychol. 8, 49\u201376 (2012).","journal-title":"Annu Rev. Clin. Psychol."},{"key":"1295_CR107","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4329\/wjr.v6.i6.261","volume":"6","author":"G Sepede","year":"2014","unstructured":"Sepede, G. et al. Sustained attention in psychosis: Neuroimaging findings. World J. Radio. 6, 261\u2013273 (2014).","journal-title":"World J. Radio."},{"key":"1295_CR108","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.lfs.2005.04.019","volume":"77","author":"RM Craft","year":"2005","unstructured":"Craft, R. M. Sex differences in behavioral effects of cannabinoids. Life Sci. 77, 2471\u20132478 (2005).","journal-title":"Life Sci."},{"key":"1295_CR109","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","volume":"92","author":"RM Craft","year":"2013","unstructured":"Craft, R. M., Marusich, J. A. & Wiley, J. L. Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci. 92, 476\u2013481 (2013).","journal-title":"Life Sci."},{"key":"1295_CR110","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.psychres.2013.12.038","volume":"215","author":"K Donoghue","year":"2014","unstructured":"Donoghue, K. et al. Cannabis use, gender and age of onset of schizophrenia: data from the \u00c6SOP study. Psychiatry Res 215, 528\u2013532 (2014).","journal-title":"Psychiatry Res"},{"key":"1295_CR111","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnbeh.2011.00064","volume":"5","author":"T Rubino","year":"2011","unstructured":"Rubino, T. & Parolaro, D. Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. Front Behav. Neurosci. 5, 64 (2011).","journal-title":"Front Behav. Neurosci."},{"key":"1295_CR112","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","volume":"33","author":"T Rubino","year":"2008","unstructured":"Rubino, T. et al. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33, 2760\u20132771 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"1295_CR113","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0269881111408956","volume":"26","author":"MP Viveros","year":"2012","unstructured":"Viveros, M. P. et al. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. J. Psychopharmacol. 26, 164\u2013176 (2012).","journal-title":"J. Psychopharmacol."},{"key":"1295_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002106","volume":"13","author":"ML Head","year":"2015","unstructured":"Head, M. L., Holman, L., Lanfear, R., Kahn, A. T. & Jennions, M. D. The extent and consequences of p-hacking in science. PLoS Biol. 13, e1002106 (2015).","journal-title":"PLoS Biol."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01295-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01295-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T01:00:44Z","timestamp":1698886844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01295-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01295-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"217"}}